LTS Expands CDMO Portfolio with Ophthalmic Drug Delivery Solutions
ANDERNACH, Germany, April 29, 2026 /PRNewswire/ — LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company specializing in advanced drug delivery systems, today announced the expansion of its service portfolio to include CDMO… Read More »LTS Expands CDMO Portfolio with Ophthalmic Drug Delivery Solutions




